PT3854388T - Sistema terapêutico transdérmico com o princípio ativo rotigotina e pelo menos um adesivo de silicone não resistente a aminas - Google Patents

Sistema terapêutico transdérmico com o princípio ativo rotigotina e pelo menos um adesivo de silicone não resistente a aminas

Info

Publication number
PT3854388T
PT3854388T PT201536216T PT20153621T PT3854388T PT 3854388 T PT3854388 T PT 3854388T PT 201536216 T PT201536216 T PT 201536216T PT 20153621 T PT20153621 T PT 20153621T PT 3854388 T PT3854388 T PT 3854388T
Authority
PT
Portugal
Prior art keywords
rotigotine
amine
silicone adhesive
therapeutic system
transdermal therapeutic
Prior art date
Application number
PT201536216T
Other languages
English (en)
Original Assignee
Luye Pharma Switzerland Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luye Pharma Switzerland Ag filed Critical Luye Pharma Switzerland Ag
Publication of PT3854388T publication Critical patent/PT3854388T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT201536216T 2020-01-24 2020-01-24 Sistema terapêutico transdérmico com o princípio ativo rotigotina e pelo menos um adesivo de silicone não resistente a aminas PT3854388T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20153621.6A EP3854388B1 (de) 2020-01-24 2020-01-24 Transdermales therapeutisches system mit dem wirkstoff rotigotin und mindestens einem nicht aminresistenten silikonkleber

Publications (1)

Publication Number Publication Date
PT3854388T true PT3854388T (pt) 2023-12-11

Family

ID=69191982

Family Applications (1)

Application Number Title Priority Date Filing Date
PT201536216T PT3854388T (pt) 2020-01-24 2020-01-24 Sistema terapêutico transdérmico com o princípio ativo rotigotina e pelo menos um adesivo de silicone não resistente a aminas

Country Status (17)

Country Link
US (1) US20230218539A1 (pt)
EP (2) EP3854388B1 (pt)
JP (1) JP2023511964A (pt)
KR (1) KR20220131941A (pt)
CN (1) CN115279351A (pt)
AU (1) AU2021210611A1 (pt)
BR (1) BR112022014665A2 (pt)
CA (1) CA3165453A1 (pt)
CL (1) CL2022001988A1 (pt)
CO (1) CO2022011900A2 (pt)
DK (1) DK3854388T3 (pt)
ES (1) ES2966170T3 (pt)
FI (1) FI3854388T3 (pt)
MX (1) MX2022009114A (pt)
PL (1) PL3854388T3 (pt)
PT (1) PT3854388T (pt)
WO (1) WO2021148634A1 (pt)

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4591622A (en) 1984-10-29 1986-05-27 Dow Corning Corporation Silicone pressure-sensitive adhesive process and product thereof
US4655767A (en) 1984-10-29 1987-04-07 Dow Corning Corporation Transdermal drug delivery devices with amine-resistant silicone adhesives
US5989586A (en) 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
DE19814084B4 (de) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
DE19830898A1 (de) 1998-07-10 2000-01-13 Hexal Ag Vorrichtung zur Verbesserung der Entnahmefähigkeit von in Beuteln verpackten, haftklebend ausgerüsteten, flächigen Substratabschnitten
US6337086B1 (en) * 1999-02-06 2002-01-08 Dow Corning Corporation Pressure sensitive adhesive compositions for transdermal drug delivery devices
EP1318843B1 (en) 2000-09-19 2013-04-17 Henkel AG & Co. KGaA Acryl adhesive useful in transdermal drug delivery systems
DE60100994T2 (de) 2001-05-08 2004-07-22 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Erzielung hoher Plasmaspiegel von Rotigotin in der Therapie von Morbus Parkinson
PT1256340E (pt) 2001-05-08 2003-12-31 Sanol Arznei Schwarz Gmbh Sistema terapeutico transdermico aperfeicoado para o tratamento da doenca de parkinson
DE10220230A1 (de) 2002-05-06 2003-11-27 Sanol Arznei Schwarz Gmbh Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
EP1386604A1 (en) 2002-07-30 2004-02-04 Schwarz Pharma Ag Improved transdermal delivery system
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
EP1386605A1 (en) 2002-07-30 2004-02-04 Schwarz Pharma Ag Improved transdermal delivery system for the administration of rotigotine
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
DE10334188B4 (de) 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10361259A1 (de) 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von Rotigotine in einem Frühstadium von Morbus Parkinson zur Prävention des weiteren Neuronenverlustes
DE102004014841B4 (de) 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
SG10201610626PA (en) 2007-11-28 2017-01-27 Ucb Pharma Gmbh Polymorphic form of rotigotine
KR101590209B1 (ko) * 2008-05-30 2016-02-01 밀란 인크. 안정화 경피 약물 전달 시스템
DE102009052972A1 (de) 2009-11-12 2011-09-15 Lts Lohmann Therapie-Systeme Ag Verfahren zur Verhinderung der Kristallisation von Arzneistoffen in einem Polymerfilm
EP3257504A1 (en) 2009-12-22 2017-12-20 UCB Biopharma SPRL Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine
EP2457565A1 (de) 2010-11-29 2012-05-30 Ratiopharm GmbH Transdermales therapeutisches System enthaltend Rotigotin
WO2012084969A1 (en) 2010-12-22 2012-06-28 Hexal Ag Adhesive composition containing rotigotine and transdermal therapeutic system comprising the adhesive composition
TW201431570A (zh) * 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
EP3007685A1 (de) * 2013-06-14 2016-04-20 tesa Labtec GmbH Dreischichtiges transdermales therapiesystem (tts)
JP6895755B2 (ja) * 2014-05-20 2021-06-30 エルテーエス ローマン テラピー−ジステーメ アーゲー 経皮送達システムにおける活性薬剤の放出を調節するための方法

Also Published As

Publication number Publication date
AU2021210611A1 (en) 2022-08-18
JP2023511964A (ja) 2023-03-23
BR112022014665A2 (pt) 2022-10-11
ES2966170T3 (es) 2024-04-18
EP3854388B1 (de) 2023-10-04
CN115279351A (zh) 2022-11-01
FI3854388T3 (fi) 2023-11-27
EP3854388A1 (de) 2021-07-28
WO2021148634A1 (de) 2021-07-29
DK3854388T3 (da) 2023-11-27
CO2022011900A2 (es) 2022-10-31
CA3165453A1 (en) 2021-07-29
MX2022009114A (es) 2022-10-27
CL2022001988A1 (es) 2023-05-19
PL3854388T3 (pl) 2024-02-26
EP4093383A1 (de) 2022-11-30
US20230218539A1 (en) 2023-07-13
KR20220131941A (ko) 2022-09-29

Similar Documents

Publication Publication Date Title
EP3659018A4 (en) MEDICAL DEVICE FOR TISSUE DETECTION AND / OR STIMULATION
GB201804502D0 (en) Biocompatible encapsulation and component stress relief for sensor enabled negative pressure wound therapy dressings
EP3766431A4 (en) MEDICAL DEVICE AND TREATMENT METHOD
MX2019011434A (es) Dispositivo de aseguramiento de cateter con ventana.
EP3769666A4 (en) Human body wearable body information measuring device and medical support system using same
EP3797833A4 (en) GOUT AND PAIN TREATMENT DEVICE
EP3510989A4 (en) CATHETER PLACEMENT DEVICE AND PLACEMENT SYSTEM
EP3730164A4 (en) IMPLANTED MEDICAL DEVICE LOADED WITH DRUG AND ITS PREPARATION METHOD
WO2016149077A3 (en) Fentanyl transdermal delivery system
EP4016524A4 (en) MEDICAL DEVICE AND MEDICAL DEVICE SYSTEM
PL3854388T3 (pl) Transdermalny system terapeutyczny z substancją czynną rotygotyną i co najmniej jednym klejem silikonowym nieodpornym na działanie amin
EP3694497C0 (en) TRANSDERMAL THERAPEUTIC SYSTEM FOR TRANSDERMAL DELIVERY OF GUANFACIN WITH A SILICONE-ACRYLIC HYBRID POLYMER
EP3693435A4 (en) ADHESIVE HYDROGEL AND MEDICAL ELECTRODE WITH IT
EP4025972A4 (en) PRETHERAPEUTIC AND THERAPEUTIC DIGITAL MEDICAL DEVICE AND METHOD
EP3983059A4 (en) EAR DEVICE AND PAIRED NERVE STIMULATION TREATMENTS
EP3817693A4 (en) ORTHOPEDIC ARCH SUPPORT DEVICE AND METHOD OF USE
EP3687472C0 (en) MEDICAL PRESSURE THERAPY DEVICE AND COMPONENTS THEREOF
GB2600270B (en) Polymer-comrprising medical devices and uses thereof
EP4061346A4 (en) COMBINATION THERAPY BASED ON CANNABIDIOL AND/OR COBICISTAT
EP3796877A4 (en) STIMULATION AND TREATMENT DEVICE
EP3733831A4 (en) ARTIFICIAL TISSUE INFUSION DEVICE AND DRUG EVALUATION METHOD USING ARTIFICIAL TISSUE
PL3357517T3 (pl) Kompozycja klejąca i element do mocowania na ludzkiej skórze
GB2607051B (en) Shoe protector device and applicator
GB202109087D0 (en) Therapeutic methods and devices
GB2605258B (en) Orthodontic system and applying methods